BEIJING, May 20 (Xinhua) — The following is a summary of published science and technology news of China.
DARK MATTER EXPLORER
Scientists have publicized the latest scientific outcomes obtained by China’s Dark Matter Particle Explorer, nicknamed “Wukong” or “Monkey King,” which could shed light on the existence of an unknown source of cosmic rays.
Scientists have managed to measure the energy spectrum of cosmic ray helium nuclei using four and half years of data recorded by Wukong, and observed the new structure of the energy spectrum, according to the project team behind the Dark Matter Particle Explorer.
INNOVATIVE CANCER DRUG
Chinese drugmaker Innovent Biologics, Inc. and the U.S.-based pharmaceutical firm Eli Lilly and Company announced on Tuesday that the U.S. Food and Drug Administration (FDA) accepted for review an application for Sintilimab, an innovative lung cancer drug jointly developed by the two companies.
The drug was approved by the National Medical Products Administration to treat relapsed/refractory classical Hodgkin’s lymphoma in December 2018 and gained approval for the first-line treatment of nonsquamous, non-small cell lung cancer in China in February this year.
China sent a new ocean-monitoring satellite into orbit from the Jiuquan Satellite Launch Center on Wednesday.
The HY-2D will form a constellation with the HY-2B and HY-2C satellites to build an all-weather and round-the-clock dynamic ocean environment monitoring system of high frequency and medium and large scale.